NOVARTIS PHARMA AG 13D and 13G filings for Precision BioSciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-27 4:37 pm Purchase | 2022-06-15 | 13G | Precision BioSciences, Inc. DTIL | NOVARTIS PHARMA AG | 413,581 16.600% | 413,581 (New Position) | Filing |